/
OKUR
$3.90-$0.03 (-0.76%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
β
of holders' portfolios
13F filers
1
institution
Market cap
$159.2M
40M shares
52-week range
$2.23 β $5.38
53% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-14.75
OnKure Therapeutics, Inc. Class A Common Stock
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3KΞ±. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
www.onkuretherapeutics.com- Employees
- 45
- IPO / List date
- Oct 7, 2024
- HQ
- BOULDER, CO
Held by traders on TradeandTell
No one on the platform currently holds OKUR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 377,250 | $1.6M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded OKUR yet.
